When did Beta Bionics, Inc. Common Stock report Q2 2025 earnings?

Beta Bionics, Inc. Common Stock (BBNX) reported Q2 2025 earnings on July 29, 2025 after market close.

What were Beta Bionics, Inc. Common Stock's Q2 2025 revenue and EPS?

Beta Bionics, Inc. Common Stock reported revenue of $23.2M and diluted EPS of $-0.39 for Q2 2025.

Did Beta Bionics, Inc. Common Stock beat estimates in Q2 2025?

Revenue beat the consensus estimate of $21.9M by $1.3M. EPS beat the consensus estimate of $-0.51 by $0.12.

Where can I find Beta Bionics, Inc. Common Stock's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0000950170-25-099652) directly on SEC EDGAR. The filing index links above go to sec.gov.

Beta Bionics, Inc. Common Stock BBNX Q2 2025 earnings

Reported July 29, 2025 · After market close

Revenue$23.2MBeat by $1.3M Diluted EPS-$0.39Beat by $0.12

Revenue estimate$21.9M

EPS estimate-$0.51

Next report

Aug 4, 2026 (in a month)

Revenue estimate$31.5M

EPS estimate-$0.62

Financials

Q2 2025

Income statement

See full

Revenue$23.2M+54.4%

Gross profit$12.5M+54.7%

Operating income-$19.9M-68.6%

Net income-$16.9M-16.6%

EPS (diluted)-$0.39+83.5%

Balance sheet

See full

Cash & equivalents$35.1M+169%

Total debt$6.7M—

Total equity$301.6M+236%

Total assets$330.0M—

Cash flow

See full

Operating cash flow-$13.6M-11.1%

CapEx$1.8M+251%

Free cash flow-$15.4M-20.6%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$681.56M—

Enterprise value$653.17M—

P/S8.7×—

Profitability

See full

Gross margin53.9%-0.3pp

Operating margin-80.1%-18.7pp

Net margin-94%-24.2pp

FCF margin-79.5%-20.7pp

Returns & leverage

See full

Debt / equity0×—

Current ratio14.7×—

Segments

By product

See full

I Let$13.4M+14.7%

Single Use Products$5.2M+102%

By geography

See full

Non Us-—

Versus estimates

Revenue

Q1 2026$27.6MBeat by $678.2K Q4 2025$32.1MBeat by $1.7M Q3 2025$27.3MMiss by $1.7M

Q2 2025$23.2MBeat by $1.3M

Q1 2025$17.6MMiss by $2.0M Q4 2024$20.4MBeat by $4.3M

Diluted EPS

Q1 2026-$0.49Beat by $0.04 Q4 2025-$0.30Beat by $0.12 Q3 2025-$0.33Beat by $0.12

Q2 2025-$0.39Beat by $0.12

Q1 2025-$0.52Miss by $0.01 Q4 2024-$1.82Miss by $1.40

Ask the moment Beta Bionics, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Beta Bionics, Inc. Common Stock report Q2 2025 earnings?: Beta Bionics, Inc. Common Stock (BBNX) reported Q2 2025 earnings on July 29, 2025 after market close.
What were Beta Bionics, Inc. Common Stock's Q2 2025 revenue and EPS?: Beta Bionics, Inc. Common Stock reported revenue of $23.2M and diluted EPS of $-0.39 for Q2 2025.
Did Beta Bionics, Inc. Common Stock beat estimates in Q2 2025?: Revenue beat the consensus estimate of $21.9M by $1.3M. EPS beat the consensus estimate of $-0.51 by $0.12.
Where can I find Beta Bionics, Inc. Common Stock's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0000950170-25-099652) directly on SEC EDGAR. The filing index links above go to sec.gov.